max), due to serious liver risks; more indicated for osteoarthritis.
– VASTAREL
Indications: vertigo, tinnitus, angina pectoris, visual field disturbances.
Side effects: tremors, gait disturbances and restless legs syndrome, parkinsonian syndromes.
Status: Restricted in France since March 2017 (re-evaluation initiated in 2011), indication limited to angina pectoris in association (initial prescription reserved for cardiologists, annual re-evaluation); withdrawal of ENT and ophthalmological indications due to lack of efficacy and serious neurological risks.
– ZYPREXA
Indications: schizophrenia and bipolar disorder.
Side effects: severe obesity, hyperglycemia, diabetes.
Already prescribed to over 20 million patients, this